| dc.contributor.author | Uysal, Mujdat | |
| dc.contributor.author | Dogru-Abbasoglu, Semra | |
| dc.contributor.author | Vural, Pervin | |
| dc.contributor.author | Bingul, Ilknur | |
| dc.contributor.author | Cil, Esra | |
| dc.date.accessioned | 2021-03-04T09:30:07Z | |
| dc.date.available | 2021-03-04T09:30:07Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Bingul I., Vural P., Dogru-Abbasoglu S., Cil E., Uysal M., "Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma", JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.31, sa.6, 2017 | |
| dc.identifier.issn | 0887-8013 | |
| dc.identifier.other | av_6895ed76-17ca-4d1d-97b8-56a57e5908d4 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/72477 | |
| dc.identifier.uri | https://doi.org/10.1002/jcla.22110 | |
| dc.description.abstract | BackgroundPapillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Vascular endothelial growth factor (VEGF) is a mediator implicated with cell proliferation, differentiation and migration, and monocyte/macrophage chemotaxis. In present study, we aimed to investigate the relationship between VEGF gene polymorphisms (G+405C, T-460C, and A-2578C) and PTC susceptibility. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
| dc.title | Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL LABORATORY ANALYSIS | |
| dc.contributor.department | Istanbul Sisli Hamidiye Etfal Training & Research Hospital , , | |
| dc.identifier.volume | 31 | |
| dc.identifier.issue | 6 | |
| dc.contributor.firstauthorID | 247252 | |
